Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative analgesia after escharotomy and skin grafting in burn patients
ChiCTR2600122729Phase 4Not yet recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in burn injury (2 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoint: Pain intensity. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR2600122729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122729.